Global TB Diagnostic Market Size, Status and Forecast 2022

TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world’s deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.
The tuberculosis diagnostics kit has undergone tremendous technological advancement to give better accuracy, quick results, and available at low cost. For the purpose of this study, the global tuberculosis diagnostics market is segmented into test types which includes radiographic methods, laboratory methods, nucleic acid testing, phage assay, cytokine detection test, detection of drug resistance, and Mantoux test.

Market Analysis and Insights: Global TB Diagnostic Market
The global TB Diagnostic market size is projected to reach US$ 2666.9 million by 2027, from US$ 1979.1 million in 2020, at a CAGR of 3.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global TB Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global TB Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global TB Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global TB Diagnostic market.

Global TB Diagnostic Scope and Market Size
TB Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global TB Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Abbott
Becton Dickinson and Company
bioMrieux
Cepheid
F. Hoffman La Roche
Hain Lifescience
Hologic Corporation
Thermo Fisher Scientific
Qiagen